ResMed (RMD)

EBITDA Growth

-5.36%

Quarterly · Period ending:

RMD logo

RMD EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported-5.36%
RMD Quarterly EBITDA YoY % (84.21% → -5.36%)
High-resolution chart · PNG

RMD ebitda growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

ResMed EBITDA Growth — Quarterly
Period endingEBITDA Growth
-5.9613%
57.6686%
15.71%
25.1668%
20.9765%
27.7125%
40.8451%
40.3968%
30.7692%
42.8571%
31.4815%
80%
91.1765%
93.1034%
116%
75%
88.8889%
123.0769%
-68.3544%
-70.1493%
112.8571%
-76.7857%
41.0714%
19.6429%
-52.1739%
60%
60%
60%
-84%
84.2105%
84.2105%
84.2105%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.